Session » Health Services Research Poster I: Diagnosis, Management and Treatment Strategies
-
Abstract Number: 113
Longitudinal, Incremental Direct Medical Costs of Giant Cell Arteritis for the First Five Years Following Diagnosis: A General Population-Based Cohort Study
-
Abstract Number: 114
Surfing the Net: Patient Empowerment or Patient Deceit? Fifteen-Year Trends on the World Wide Web Information for Patients with Rheumatoid Arthritis
-
Abstract Number: 115
Validation of a Large Rheumatoid Arthritis Cohort and Preventive Health Screening
-
Abstract Number: 116
The Effect of the Formal Approval of Colchicine on Utilization of Emergency Department and Rheumatology Outpatient Services By Patients with Gout
-
Abstract Number: 117
Same Day Rheumatology Access Clinic in an Academic Health Care Center
-
Abstract Number: 118
Identifying the Investment Needed to Generate a Durable Prednisone Dose Decrement
-
Abstract Number: 120
Validity of the Inpatient Diagnosis of Systemic Lupus Erythematosus: Clarifying Hospital Readmission Rates
-
Abstract Number: 121
Serum Uric Acid Levels and Gout Flares in a US Managed Care Setting
-
Abstract Number: 122
General Practitioners’ Perceptions of Methotrexate and Anti-TNF Therapies: A Qualitative Study
-
Abstract Number: 123
An Economic Evaluation of Tofacitinib (Xeljanz) Treatment in Rheumatoid Arthritis: Modeling the Cost of Treatment Strategies in the US
-
Abstract Number: 124
Experiences with a Structured Questionnaire for Administrative Personnel to Discriminate Urgent and Non-Urgent Rheumatic Patients Referred from Primary to Secondary Care
-
Abstract Number: 125
Implementation of a Bone Health Team Markedly Improves Osteoporosis Screening, Diagnosis and Treatment Initiation Rates Compared to Standard Primary Care Practice
-
Abstract Number: 127
Potential Use of Healthcare Databases for Post-Marketing Surveillance Registry: an Example Using Ustekinumab
-
Abstract Number: 128
Economic Burden and Treatment Patterns of Cycling Between Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) Among Patients with Rheumatoid Arthritis (RA)
-
Abstract Number: 129
Rheumatologists’ Approaches to Diagnosis and Treatment of Depression
-
Abstract Number: 130
Disease Activity Patterns in Incident Onset Rheumatoid Arthritis Patients in the First 3-Years of Follow up
-
Abstract Number: 131
Frequency of Lipid Testing and Management Among Rheumatoid Arthritis Patients Compared to the General Population and Patients with Diabetes
-
Abstract Number: 132
Delivering a One-Stop, Integrated, Patient-Centred Service for Patients with Rheumatic Diseases. the Finnish Approach
-
Abstract Number: 133
Advocating for Rheumatoid Arthritis and Cardiovascular Health (ARCH) in a Tertiary Referral Center: A Collaborative and Systems-Based Approach to Improve Access to Care
-
Abstract Number: 134
Axial Spondyloarthritis: Validation of an Inter-Professional Model of Care
-
Abstract Number: 135
Limitations of Treat-to-Target in Rheumatoid Arthritis: Joint Damage Appears As Severe As Inflammation in Contemporary Care at One Site
-
Abstract Number: 136
Physician Patterns of Patient Care in Systemic Lupus Erythematosus: Are We Ordering Unnecessary Tests?
-
Abstract Number: 137
Willingness to Pay for Highly Effective Drug Treatments in Brazilian Rheumatoid Arthritis Patients
-
Abstract Number: 139
One-Year Cost of Etanercept, Adalimumab, and Infliximab per Treated Patient with Chronic Inflammatory Arthritides in US Veterans
-
Abstract Number: 140
Identifying Psoriatic Arthritis and Ankylosing Spondylitis Patients Responsible for the Highest Costs of Care: Data from a Large US Cohort
-
Abstract Number: 141
Improved Follow-up of Hypertension in Rheumatology Patients: Results of a Pilot
-
Abstract Number: 142
Exploration of General Practioners’ Difficulties with Methotrexate and Anti-TNF Therapies in Routine Practice
-
Abstract Number: 143
Fiber Optic Intubation in Patients with Rheumatoid Arthritis Who Had a Surgical Procedure
-
Abstract Number: 144
One-Year Costs Following Switching Versus Dose-Escalation Among Prevalent Tumor Necrosis Factor Inhibitors Used for Rheumatoid Arthritis
-
Abstract Number: 145
Economic Burden of Switching to an Anti-Tumor Necrosis Factor (anti-TNF) Versus a Non-Tumor Necrosis Factor (non-TNF) Biologic Therapy Among Patients with Rheumatoid Arthritis
-
Abstract Number: 146
Rates of Lipid Testing and Statin Prescription Filling Among U.S. Medicaid Recipients with SLE, 2007-2010
-
Abstract Number: 147
Fatigue, Coping, Sleeping Disorders and Productivity Were Still Not Frequently Reported in Rheumatoid Arthritis Trials Published in 2014-2015: A Systematic Literature Review
-
Abstract Number: 148
An Evaluation of the Virtual Monitoring Clinic, a Novel Nurse-Led Telemonitoring Service for Monitoring Patients with Stable Rheumatoid Arthritis